XML 32 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
[1]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock, Common [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
[1]
Total
Balance, beginning of period at Dec. 31, 2022 $ 97,204 $ (649) $ 156,958 $ (3,260) $ (11,675) $ (649) $ 239,227
Balance, beginning of period (in shares) at Dec. 31, 2022 10,584            
Increase (Decrease) in Stockholders' Equity              
Net Income (Loss)     39,707       39,707
Other comprehensive income, net of tax       523     523
Dividends on common stock $ 187   (4,908)       (4,721)
Dividends on common stock (in shares) 7            
Share-based compensation [2] $ 3,035           3,035
Share-based compensation (in shares) [2] 128            
Treasury stock purchased, at cost         (15,692)   (15,692)
Treasury stock purchased, at cost (in shares) (656)            
Balance, end of period at Dec. 31, 2023 $ 100,426   191,108 (2,737) (27,367)   $ 261,430
Balance, end of period (in shares) at Dec. 31, 2023 10,063           10,063
Increase (Decrease) in Stockholders' Equity              
Net Income (Loss)     41,450       $ 41,450
Other comprehensive income, net of tax       630     630
Dividends on common stock $ 206   (5,227)       (5,021)
Dividends on common stock (in shares) 7            
Share-based compensation [2] $ 3,304           3,304
Share-based compensation (in shares) [2] 185            
Treasury stock purchased, at cost         (6,210)   (6,210)
Treasury stock purchased, at cost (in shares) (229)            
Balance, end of period at Dec. 31, 2024 $ 103,936   $ 227,331 $ (2,107) $ (33,577)   $ 295,583
Balance, end of period (in shares) at Dec. 31, 2024 10,026           10,026
[1] See further disclosure surrounding CECL transition in Note 1 to the Consolidated Financial Statements.
[2] Includes the issuance of common stock under employee benefit plans, which includes nonqualified stock options and restricted stock expense related entries, employee option exercises and the tax benefit of options exercised.